Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations

Isavuconazole (ISA) is a triazole antifungal agent recommended for treatment of invasive aspergillosis or mucormycosis. The objective of this study was to evaluate ISA levels in a real world setting in a mixed patient cohort including patients with non-malignant diseases and extracorporeal treatment...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Fungi (Basel)
Autori principali: Zurl, Christoph, Waller, Maximilian, Schwameis, Franz, Muhr, Tina, Bauer, Norbert, Zollner-Schwetz, Ines, Valentin, Thomas, Meinitzer, Andreas, Ullrich, Elisabeth, Wunsch, Stefanie, Hoenigl, Martin, Grinschgl, Yvonne, Prattes, Juergen, Oulhaj, Abderrahim, Krause, Robert
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7344482/
https://ncbi.nlm.nih.gov/pubmed/32580296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jof6020090
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi